It has been alternatively called cranial arteritis or temporal arteritis, reflecting the most commonly affected vessels. However, this terminology minimizes the systemic nature of this vasculitis ...

Unlike PMR, temporal arteritis requires immediate medical attention. Delays in treatment might have major repercussions, such as blindness or stroke. As per the Arthritis Foundation, If you are ...

Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a ...

Also referred to as temporal arteritis, GCA is an autoimmune condition affecting medium and large arteries. Discovered and developed by the company’s scientists, Rinvoq is a selective and ...

Find effective medications for 'Temporal Arteritis treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to ...

Visual loss is the most feared complication in temporal arteritis, and extracranial arteries and/or aorta are more often involved in GCA than previously estimated. No specific laboratory parameter ...

Use of upadacitinib in GCA is not currently approved in the EU. Giant cell arteritis (GCA), also known as temporal arteritis, is an autoimmune disease of medium and large arteries, characterized by ...

Based Performance of Inflammatory Markers in Giant Cell Arteritis,” published in the March 2025 issue of American Journal of ...

Dr. Cohen has has worked on more claims relating to Cerebrovascular Disease, Transient Ischemic Attack (TIA) and Temporal Arteritis than other providers in the area. At present, Dr. Cohen has ...